| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
3,513,100 | 3,436,500 | 3,366,400 | 2,964,500 | 2,530,700 |
| Cost of Revenue
|
-1,838,800 | -1,858,800 | -1,716,900 | -1,451,200 | -1,225,000 |
|
Gross Profit
|
1,674,300 | 1,577,700 | 1,649,500 | 1,513,300 | 1,305,700 |
| Selling, General and Administrative Expenses
|
-954,700 | -946,500 | -893,800 | -729,400 | -607,400 |
|
Research and Development Expenses
|
-387,200 | -395,200 | -376,500 | -294,800 | -235,900 |
|
Operating Income/Expenses
|
-1,341,900 | -1,341,700 | -1,270,300 | -1,024,200 | -843,300 |
|
Total Operating Profit/Loss
|
332,400 | 236,000 | 379,200 | 489,100 | 462,400 |
| Total Net Finance Income/Expense
|
-31,200 | -46,700 | -38,600 | -5,200 | -12,000 |
| Net Investment Income
|
69,600 | 17,500 | 23,700 | -13,300 | -5,800 |
| Irregular Income/Expenses
|
-438,000 | -171,700 | -147,700 | 84,600 | -23,500 |
|
Other Income/Expense, Non-Operating
|
-3,700 | -13,100 | -9,700 | -11,000 | -7,200 |
|
Non-Operating Income/Expenses, Total
|
-403,300 | -214,000 | -172,300 | 55,100 | -48,500 |
|
Pretax Income
|
-70,900 | 22,000 | 206,900 | 544,200 | 413,900 |
|
Provision for Income Tax
|
-42,300 | -29,300 | -91,400 | -117,700 | -116,400 |
|
Earnings from Equity Interest, Post-Tax
|
-2,500 | -1,000 | -1,700 | 2,000 | 1,000 |
|
Net Income from Continuing Operations
|
-115,700 | -8,300 | 113,800 | 428,500 | 298,500 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-115,700 | -8,300 | 113,800 | 428,500 | 298,500 |
|
Non-Controlling/Minority Interests
|
-7,700 | -300 | -700 | -1,300 | -1,900 |
|
Net Income after Non-Controlling/Minority Interests
|
-123,400 | -8,600 | 113,100 | 427,200 | 296,600 |
| Preferred/Other Stock Distribution
|
-43,900 | -13,900 | 0 | 0 | -- |
|
Net Income Available to Common Stockholders
|
-167,300 | -22,500 | 113,100 | 427,200 | 296,600 |
|
Diluted Net Income Available to Common Stockholders
|
-167,300 | -22,500 | 113,100 | 427,200 | 296,600 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-42,800 | 67,500 | 245,500 | 553,100 | 427,200 |
|
EBITDA
|
185,700 | 287,800 | 429,300 | 668,000 | 515,900 |
|
Normalized EBITDA
|
1,024,700 | 632,000 | 638,300 | 599,800 | 549,000 |
|
Normalized Income
|
310,800 | 278,100 | 360,500 | 379,700 | 348,900 |
|
Total Unusual Items
|
839,000 | 344,200 | 209,000 | -11,800 | 42,700 |
|
Total Unusual Items Excluding Goodwill
|
529,600 | 247,700 | 209,000 | -11,800 | 42,700 |
|
Tax Effect of Unusual Items
|
135,418.72 | 52,017 | 43,890 | -2,548.80 | 11,998.70 |
12/31/2022 - 9/4/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade